Combined treatment approach in surgical management of XXXX : a preliminary report.

@entity1 @entity5 @entity900 @entity189 @entity5713 @entity3 @entity902 @entity3137 @entity1487 @entity1681
Surgical management of squamous cell @entity189 continues to be a controversial area in thoracic surgery. In a series of 20 @entity1 , 15 received preoperative chemotherapy with cis- @entity902 ( @entity900 ), 2 received @entity900 plus @entity1487 , and 3 received @entity900 plus @entity5713 . Eighteen @entity1 underwent en bloc esophagogastrectomy and postoperative radiation therapy. All @entity1 were staged preoperatively by thoracoabdominal computed axial tomographic scan, bone scan, bronchoscopy, esophagoscopy, and barium swallow. @entity1 with liver or bone @entity3 were excluded. The majority of @entity1 received preoperative @entity1681 . Eighteen of the 20 @entity1 completed the study with a follow-up of 12 to 24 months. There was 1 operative death, and 3 @entity1 were in the hospital for more than three weeks after operation before they were discharged. Fourteen of the 18 @entity1 survived for a year, and 11 survived for 12 to 24 months. @entity3137 and @entity5 burden based on preoperative barium swallow and endoscopy was evident in 11 of 18 @entity1 , but in no @entity1 was the @entity5 completely eradicated by preoperative chemotherapy. Although follow-up is short, this treatment regimen involving a combined treatment offers hope in the palliation of this disease.
